253 related articles for article (PubMed ID: 31124539)
1. Intravenous tocilizumab in idiopathic pediatric uveitis with refractory cystoid macular edema - A case report.
Babu K; Sudheer B; Rao AP
Indian J Ophthalmol; 2019 Jun; 67(6):975-977. PubMed ID: 31124539
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous Tocilizumab for Cystoid Macular Edema Secondary to Juvenile Idiopathic Arthritis (JIA)-associated Uveitis: A Case Report.
Adán A; Moll-Udina A; Ramirez J; Llorenç V
Ocul Immunol Inflamm; 2021 Jan; 29(1):6-8. PubMed ID: 31589540
[No Abstract] [Full Text] [Related]
3. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.
Vegas-Revenga N; Calvo-Río V; Mesquida M; Adán A; Hernández MV; Beltrán E; Valls Pascual E; Díaz-Valle D; Díaz-Cordovés G; Hernandez-Garfella M; Martínez-Costa L; Calvo I; Atanes A; Linares LF; Modesto C; González-Vela C; Demetrio-Pablo R; Aurrecoechea E; Cordero M; Domínguez-Casas LC; Atienza-Mateo B; Martín-Varillas JL; Loricera J; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
Am J Ophthalmol; 2019 Apr; 200():85-94. PubMed ID: 30660771
[TBL] [Abstract][Full Text] [Related]
4. TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA.
Mesquida M; Molins B; Llorenç V; Hernández MV; Espinosa G; Sainz de la Maza M; Adán A
Retina; 2018 Jul; 38(7):1361-1370. PubMed ID: 28520640
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Macular Edema in Uveitis as Diagnosed by Optical Coherence Tomography in Tertiary Eye Center.
Gupta S; Shah DN; Joshi SN; Aryal M; Puri LR
Nepal J Ophthalmol; 2018 Jan; 10(19):39-46. PubMed ID: 31056575
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal diclofenac for treatment of refractory uveitis-associated cystoid macular oedema: A before and after clinical study.
Kianersi F; Rezaeian-Ramsheh A; Pourazizi M; Kianersi H
Acta Ophthalmol; 2018 May; 96(3):e355-e360. PubMed ID: 29369543
[TBL] [Abstract][Full Text] [Related]
7. Disease of the Year: Differential Diagnosis of Uveitic Macular Edema.
Agarwal A; Pichi F; Invernizzi A; Gupta V
Ocul Immunol Inflamm; 2019; 27(1):72-88. PubMed ID: 30273513
[TBL] [Abstract][Full Text] [Related]
8. Spectral domain optical coherence tomography changes following intravitreal dexamethasone implant, Ozurdex® in patients with uveitic cystoid macular edema.
Bansal P; Agarwal A; Gupta V; Singh R; Gupta A
Indian J Ophthalmol; 2015 May; 63(5):416-22. PubMed ID: 26139803
[TBL] [Abstract][Full Text] [Related]
9. Swept-source Optical Coherence Tomography Angiography Findings in Uveitic Cystoid Macular Edema.
Khochtali S; Abroug N; Megzari K; Gargouri MA; Ksiaa I; Ben Amor H; Saihi E; Khairallah M
Ocul Immunol Inflamm; 2019; 27(8):1211-1223. PubMed ID: 31652092
[No Abstract] [Full Text] [Related]
10. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
Dwivedi R; Tiroumal S
Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
[TBL] [Abstract][Full Text] [Related]
11. Tocilizumab treatment for refractory uveitis-related cystoid macular edema.
Adán A; Mesquida M; Llorenç V; Espinosa G; Molins B; Hernández MV; Pelegrín L
Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2627-32. PubMed ID: 23893042
[TBL] [Abstract][Full Text] [Related]
12. Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab.
Rahman HT; Yeh S; Bergstrom CS
J Ocul Pharmacol Ther; 2013 Apr; 29(3):360-2. PubMed ID: 23061416
[TBL] [Abstract][Full Text] [Related]
13. Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment.
Deuter CME; Zierhut M; Igney-Oertel A; Xenitidis T; Feidt A; Sobolewska B; Stuebiger N; Doycheva D
Ocul Immunol Inflamm; 2017 Apr; 25(2):215-220. PubMed ID: 26731514
[TBL] [Abstract][Full Text] [Related]
14. [Optical coherence tomography in the diagnosis and follow-up of patients with uveitic macular edema].
Reinthal EK; Völker M; Freudenthaler N; Grüb M; Zierhut M; Schlote T
Ophthalmologe; 2004 Dec; 101(12):1181-8. PubMed ID: 15156343
[TBL] [Abstract][Full Text] [Related]
15. Anti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitis.
Schaap-Fogler M; Amer R; Friling R; Priel E; Kramer M
Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):633-40. PubMed ID: 24366669
[TBL] [Abstract][Full Text] [Related]
16. Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography.
Markomichelakis NN; Halkiadakis I; Pantelia E; Peponis V; Patelis A; Theodossiadis P; Theodossiadis G
Ophthalmology; 2004 May; 111(5):946-53. PubMed ID: 15121373
[TBL] [Abstract][Full Text] [Related]
17. Difluprednate for the Treatment of Uveitic Cystoid Macular Edema.
Schallhorn JM; Niemeyer KM; Browne EN; Chhetri P; Acharya NR
Am J Ophthalmol; 2018 Jul; 191():14-22. PubMed ID: 29580977
[TBL] [Abstract][Full Text] [Related]
18. Twenty-Four Months Follow-Up of Intravitreal Bevacizumab Injection Versus Intravitreal Triamcinolone Acetonide Injection for the Management of Persistent Non-Infectious Uveitic Cystoid Macular Edema.
Lasave AF; Schlaen A; Zeballos DG; Díaz-Llopis M; Couto C; El-Haig WM; Arevalo JF
Ocul Immunol Inflamm; 2019; 27(2):294-302. PubMed ID: 29157128
[TBL] [Abstract][Full Text] [Related]
19. Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema.
Lasave AF; Zeballos DG; El-Haig WM; Díaz-Llopis M; Salom D; Arevalo JF
Ocul Immunol Inflamm; 2009; 17(6):423-30. PubMed ID: 20001264
[TBL] [Abstract][Full Text] [Related]
20. Medical treatment of macular edema in patients with uveitis.
Rojas B; Zafirakis P; Christen W; Markomichelakis NN; Foster CS
Doc Ophthalmol; 1999; 97(3-4):399-407. PubMed ID: 10896356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
